Delirium Market

Growing aging population is to boost the market growth

The aging population is a significant driver of the delirium market. As the global population experiences a demographic shift towards older adults, the prevalence of delirium increases. Older individuals are more susceptible to delirium due to factors such as underlying health conditions, cognitive impairments, polypharmacy, and hospitalization. The physiological changes associated with aging, such as alterations in neurotransmitters and decreased cognitive reserve, also contribute to the vulnerability to delirium. The aging population's impact on the delirium market is multifaceted. Firstly, it leads to a greater number of delirium cases, creating a higher demand for diagnostic tools, interventions, and management strategies.

Secondly, the complex medical needs of older patients require tailored approaches to delirium prevention and management. This drives the development of specialized programs, protocols, and guidelines for geriatric delirium care. In October 2022, according to the WHO, the number of people 60 and older will rise from 1 Million in 2020 to 1.4 Million. The number of people 60 and older in the world will double (2.1 Million) by the year 2050. Between 2020 and 2050, there will be 426 million more people who are 80 years of age or older.

Additionally, the aging population influences research and development efforts focused on understanding the underlying mechanisms of delirium and developing age-specific interventions. It also highlights the importance of interdisciplinary collaboration and training to equip healthcare professionals with the knowledge and skills necessary for effective delirium management in older adults. Overall, the growing aging population is a driving force behind the expansion and advancement of the delirium market.

The Global Delirium Market Industry is projected to experience substantial growth over the coming years. The market is expected to reach a value of 0.34 USD Billion in 2024, with a significant increase to 0.6 USD Billion by 2035. This growth is indicative of a compound annual growth rate of 5.32% from 2025 to 2035. Such projections highlight the increasing recognition of delirium as a critical health issue and the ongoing efforts to improve its management and treatment across various healthcare settings.

The Global Delirium Market Industry is experiencing growth due to the increasing incidence of delirium among hospitalized patients. Studies indicate that delirium affects approximately 15 to 30 percent of hospitalized older adults, particularly in intensive care units. This rising prevalence necessitates improved diagnostic and treatment options, thereby driving market expansion. As the global population ages, the number of individuals at risk for delirium is expected to rise, contributing to the market's projected value of 0.34 USD Billion in 2024. This trend underscores the need for healthcare systems to address delirium more effectively.

Technological advancements in diagnostic tools are significantly influencing the Global Delirium Market Industry. Enhanced screening methods and tools, such as the Confusion Assessment Method, are enabling healthcare professionals to identify delirium more accurately and promptly. These innovations not only improve patient outcomes but also facilitate timely interventions, which are crucial in managing delirium. As a result, the market is likely to see an increase in demand for these advanced diagnostic tools, contributing to the projected growth rate of 5.32% CAGR from 2025 to 2035. This growth reflects the ongoing commitment to improving delirium management.

The integration of telehealth services into healthcare systems is emerging as a key driver for the Global Delirium Market Industry. Telehealth platforms facilitate remote monitoring and consultations, allowing healthcare providers to manage delirium cases more effectively, especially in rural or underserved areas. This approach not only enhances access to care but also supports timely interventions, which are critical in managing delirium. As telehealth continues to gain traction, it is likely to contribute to the market's growth, aligning with the projected CAGR of 5.32% from 2025 to 2035, as healthcare systems adapt to evolving patient needs.

The Global Delirium Market Industry is benefiting from increased research and development initiatives aimed at understanding and treating delirium. Government and academic institutions are investing in studies that explore the underlying mechanisms of delirium and potential therapeutic interventions. This focus on research is likely to lead to the development of novel treatment options, enhancing the overall management of delirium. As these initiatives progress, they are expected to contribute to the market's growth trajectory, supporting the anticipated increase in market value to 0.6 USD Billion by 2035.

There is a growing awareness among healthcare professionals regarding the implications of delirium, which is positively impacting the Global Delirium Market Industry. Educational initiatives and training programs are being implemented to enhance understanding of delirium's symptoms and management strategies. This heightened awareness is likely to lead to earlier detection and treatment, thereby improving patient outcomes. As healthcare providers become more knowledgeable, the demand for effective delirium management solutions is expected to rise, further contributing to the market's anticipated growth to 0.6 USD Billion by 2035.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Delirium market accounted for the largest market share in 2022 due to aging population and a rise in chronic illnesses, there is an increased awareness of delirium as a critical aspect of patient care. The region's well-established healthcare infrastructure and advanced medical research contribute to the growth of diagnostic and therapeutic innovations in delirium management. Hospitals and healthcare facilities across North America are integrating specialized protocols, training programs, and advanced technologies to enhance delirium diagnosis and treatment.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: DELIRIUM MARKET BY REGION 2022 & 2032

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Europe Delirium market is expected to account for the second-largest market share due to the favorable health policies and trend towards integrating health services, including counseling. Further, the German Delirium market was attributed to holding the largest market share, and France Delirium market is expected to fastest-growing market in the European region.

The Asia-Pacific healthcare counseling market is expected to grow at the fastest rate from 2024 to 2032. This is due to the rising spending in healthcare, quickly evolving healthcare infrastructure, growing awareness regarding Delirium, and growing population in the region. Moreover, China’s Delirium market is expected to hold the largest market share, and India Delirium market is expected fastest-growing market in the Asia-Pacific region.

The Rest of the World includes the Middle East, Africa, and Latin America. The main factors influencing the growth of Delirium are in the Middle East and Africa. As the region experiences population growth and an increase in age-related conditions, the awareness and recognition of delirium as a significant healthcare concern are on the rise. Healthcare providers in the Middle East and Africa are progressively focusing on implementing effective diagnostic and therapeutic strategies for delirium management.

The Delirium Market is characterized by the presence of many global, regional, players. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the globe with diverse Type portfolios. Companies such as Otsuka Pharmaceutical Co., Ltd (Japan), Mylan N.V (US), Teva Pharmaceutical Industries Ltd (Israel), Zydus Group (India), Glenmark Pharmaceuticals Ltd (India), Pfizer (India), Mylan N.V (US), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Novartis AG (Switzerland) dominate the Delirium Market due to Type differentiation, financial stability, strategic services, and diversified regional presence.

The players are focused on investing in extensive research and development as well. Furthermore, they adopt strategic growth initiatives, such as expansion, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the global Delirium industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs.